Journal of Clinical & Experimental Dermatology Research
Open Access
ISSN: 2155-9554
ISSN: 2155-9554
Dermatology Service, Out-patient Hair Clinics, Salerno, Italy
Research Article
Efficacy, Tolerability and Cosmetic Acceptability of a Growth Factors, Caffeine, Taurine and a Chelating Complex-Based Gel in Subjects with Hair Loss Alone or In Combination with Drugs Treatments: A Real Life, Multicentre, Assessor-Blinded, 6-Month T
Author(s): Alfredo Caruso, Angelo Massimiliano D'Erme, Anna Bordin, Antonella Balducci, Antonello Bonifati, Antonina Agolzer, Antonio Carpentieri, Antonio Del Sorbo, Carlotta Guaraldi, Chiara Galloni, Claudio Zeccara, Daniela Barbaso, Davide Ciccone, Davide Fattore, Diletta Bonciani, Federica Cecchi, Federica Guicciardi, Francesca Serra, Gianfranco Del Plato, Gianni Montesi, Luigia Panariello, Giovanni Profeta, Giuseppe Gallo, Ilaria Minnetti, Ilenia Vella, Lisa Cecchini, Luciano Mavilia, Manuela de Massis, Mara Lombardi, Marco Rovaris, Maria Cristina Fiorucci, Marina Favaro, Marina Rosella, Matteo Basso, Patrizia Ghidini, Piera Fileccia, Pierluigi Bruni, Riccardo Bono, Stefania Greco, Francesca Colombo and Massimo Milani*
Introduction: We evaluated efficacy, tolerability, and cosmetic acceptability of a gel containing growth factors, taurine,
caffeine and iron chelating complex (GFmgel) in subjects with hair loss (AGA/FAGA, TE) in a real-life condition.
Materials and methods: 471 subjects (273 women) with hair loss conditions (AGA/FAGA: n=269; or chronic
TE, n=202) were enrolled. Eligible subjects could be naïve (no specific hair loss treatments) or treated with anti-hair
loss drugs since at least 6 months. GFmgel (12.5 ml per application) should be applied on the scalp once weekly.
The primary outcome was the Global Assessment Score (GAS) using a 7-point scale in comparison with baseline
condition after 6 months of therapy. At baseline a global picture of the scalp was performed to be used for the GAS
evaluation. A total of 229 subjects .. View More»
DOI:
10.35841/2329-9509.22.13.623